Franklin Resources’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Franklin Resources's ALLO Position: Q3 2026 in Review
Franklin Resources opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 483,157 shares worth $575K. The stake represents ﹤0.01% of the portfolio and ranks #2514 among its holdings. This is a return to the name: Franklin Resources previously reported a position in ALLO as recently as Q3 2023.
Franklin Resources first reported a position in ALLO in Q4 2018 and has held it in 8 quarters since. The position peaked at $22.6M in Q1 2019. 197 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Franklin Resources held 483,157 shares of Allogene Therapeutics worth $575K as of Q3 2026.
- Allogene Therapeutics was a new Franklin Resources position in Q3 2026.
- Allogene Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #2514 holding.
- Franklin Resources first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 8 quarters since.
- Franklin Resources's Allogene Therapeutics position peaked at $22.6M in Q1 2019.
- 197 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.